Led China Alliance team to coordinate with Global and local functional teams to support ONC/Innovative Products business on market access, products extension and new business development, develop & manage change to support ONC business fast growth in China.

Led the team to develop the medical strategy plan including clinical trials, publication plan, communication plan, and ensured the implementation within planned timeline and budgets;Provided medical expertise and benefit/risk evaluation on medical compound/diagnosis/medical device, to guide the company’s portfolio management;Provided medical advice in new product’s regulatory review, communicated with CDE, and be responsible for document preparation according to CDE demands.

➢ Led the delegated Medical Sciences Teams, Clinical Operations Team, MSL and Qaulity & Compliance Team to support all launched products’ lifecycle management in Oncology/RA/Hepatitis/Transplantation➢ Developed short term/long term medical strategic plans of key products, including PhII/PhIII/PhIV trial design; local/regional/global trials management, trial result publications and communications.➢ Provided medical expertise on new products/indications development plan as member of Emerging Market and China portfolio project team

➢ Developed marketing strategies plans to achieve the leadership position in the Oncology area➢ Built up Roche Oncology Branding through activities beyond and between our brands➢ Input in global strategy plan as an appointed member of International Business Team (IBT)

Reponsible for all Oncology products: Mabthera, Xeloda, Heceptin, Kytril, Bondronat, and new onology products pre-launch Tarceva and Avastin

Responsible for new oncology products launch: Xeloda and Hercepin.

➢ Responsible for all launched products’ trial development and trial monitoring➢ Provided medical information support with KOLs and provide training in different therapeutic areas to Marketing/Sales Dept.➢ Responsible for all products’ professional media release

Responsible for oncology products: Intron, Leucomax, FugeralDeveloped 3-year marketing plan and sales forecast based on marketing potential;Developed product marketing strategies and marketing promotion MIX through team work;Promotional programs monitoring and budget control.

Responsible for Leucomax:

Reponsible for LeucomaxGM award in 1996 for outstanding achievement and contribution

Responsible for Leucomax

Responsible products : Intron, Leucomax, Fugural Responsible areas : Shanghai, Hangzhou, AnhuiTop sales in the year of 1994